Decoding Senescence-Driven Heterogeneity in Early-Onset Colorectal Cancer for Prognostic and Therapeutic Stratification

Dec 4, 2025·
Du CAI
Du CAI
1st Author
Ming-Ru MAI
Ming-Ru MAI
Co-1st Author
Ren-De HUANG
Ren-De HUANG
Co-1st Author
Hao-Ning QI
Hao-Ning QI
,
Xingzhi Feng
,
Qianling Gao
Yin-Meng ZHANG
Yin-Meng ZHANG
Cheng-Hang LI
Cheng-Hang LI
,
Xiaojian Wu
Co-Corresponding Author
,
Yize Mao
Co-Corresponding Author
,
Zihuan Yang
Co-Corresponding Author
Feng GAO
Feng GAO
Corresponding Author
· 0 min read
Abstract
Early-onset colorectal cancer (EOCRC) is clinically aggressive and lacks precise treatment stratification tools. This work integrates multi-omics data from 2961 patients and reveals distinct senescence-driven EOCRC subtypes with markedly different prognosis and tumor microenvironment characteristics. The proposed EO-Senscore model quantifies senescence states and helps identify patients more likely to benefit from immunotherapy, chemotherapy, or anti-senescence strategies.
Type
Publication
Cancer Science
publication
Du CAI
Authors
Postdoc
I focus on leveraging explainable AI and large foundation models to advance medical imaging and digital pathology in colorectal cancer research.
Ming-Ru MAI
Authors
Research Student
I am a research student interested in colorectal cancer and bioinformatics, with a focus on data-driven biomedical analysis.
Ren-De HUANG
Authors
Research Student
I am a research student working on AI methods for colorectal cancer analysis and clinical decision support.
Hao-Ning QI
Authors
Postdoc
I am a postdoctoral researcher working on AI for colorectal cancer with a focus on clinically actionable models.
Yin-Meng ZHANG
Authors
PhD Student
I am a PhD student working on AI methods for colorectal cancer research and translational clinical applications.
Cheng-Hang LI
Authors
Research Assistant
I am a research assistant focusing on deep learning, multimodal feature fusion, and medical AI system development.
Feng GAO
Authors
Professor
My research leverages AI and big data to improve diagnostics, prognostics, and ultimately, outcomes in cancer and other biomedical fields.